# Effect of CAFfeine on Cognition in Alzheimer's Disease

> **NCT04570085** · PHASE3 · RECRUITING · sponsor: **University Hospital, Lille** · enrollment: 248 (estimated)

## Conditions studied

- Alzheimer Disease

## Interventions

- **DRUG:** Caffeine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04570085
- **Lead sponsor:** University Hospital, Lille
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-03-01
- **Primary completion:** 2027-12
- **Final completion:** 2027-12
- **Target enrollment:** 248 (ESTIMATED)
- **Last updated:** 2026-04-20

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04570085

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04570085, "Effect of CAFfeine on Cognition in Alzheimer's Disease". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04570085. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*